PT Etana Biotechnologies Indonesia
Latest round
- Series B
Last raised
- Sep 2022
Total raised
- Undisclosed
Investors
- 2
About PT Etana Biotechnologies Indonesia
Based in Jakarta, Indonesia, and founded in 2014, PT etana biotechnologies Indonesia operates as a biotechnology company that develops metabolic pharmaceuticals for the treatment of autoimmune diseases and cancer. The firm offers various biopharmaceutical products which help in the treatment of various medical conditions which includes cancers, and metabolic and autoimmune diseases. As of 2022, It will produce epoetin alfa products which will be sold under the name of Renogen and could be used by patients undergoing dialysis treatment. It will also offer Bevagen which is a Bevacizumab biosimilar product that will be used for the treatment of advanced non-small cell lung cancer and metastatic colorectal cancer. The firm will produce monoclonal antibody drugs which will serve as substitute antibodies that can restore or enhance the immune system's attack on cancer cells.
Who invested in PT Etana Biotechnologies Indonesia
2 investors across 1 round
See all investors in PT Etana Biotechnologies Indonesia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 27, 2022
Amount
Undisclosed
Investors
Questions about PT Etana Biotechnologies Indonesia
Who invested in PT Etana Biotechnologies Indonesia?
PT Etana Biotechnologies Indonesia has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PT Etana Biotechnologies Indonesia raised?
PT Etana Biotechnologies Indonesia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PT Etana Biotechnologies Indonesia last raise money?
PT Etana Biotechnologies Indonesia's most recent round on record is a Series B, in Sep 2022.
What does PT Etana Biotechnologies Indonesia do?
Based in Jakarta, Indonesia, and founded in 2014, PT etana biotechnologies Indonesia operates as a biotechnology company that develops metabolic pharmaceuticals for the treatment of autoimmune diseases and cancer.
Where is PT Etana Biotechnologies Indonesia headquartered?
PT Etana Biotechnologies Indonesia is headquartered in Jakarta, Indonesia.
Which VCs invest in companies like PT Etana Biotechnologies Indonesia?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at PT Etana Biotechnologies Indonesia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like PT Etana Biotechnologies Indonesia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.